Isoniazid preventive therapy for HIV-infected people: Evidence to support implementation

AIDS

Volumn 24, Issue SUPPL. 5, 2010, Pages

  Eldred, Lois J ^a   Churchyard, Gavin ^b   Durovni, Betina ^c   Godfrey Faussett, Peter ^d   Grant, Alison D ^d   Getahun, Haileyesus ^e   Chaisson, Richard E ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AURUM INSTITUTE   (South Africa)

^c Health Secretariat of Rio de Janeiro City   (Brazil)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DRUG SAFETY; EDITORIAL; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFECTION CONTROL; MIXED INFECTION; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; SILICOSIS; TREATMENT FAILURE; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOSIS CONTROL;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTITUBERCULAR AGENTS; EVIDENCE-BASED MEDICINE; HIV INFECTIONS; HUMANS; ISONIAZID; TUBERCULOSIS;

EID: 78649253501     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/01.aids.0000391009.95149.ec     Document Type: Editorial

References (21)

1. World Health Organization. WHO three I's meeting: intensified case finding, isoniazid preventive therapy and TB infection control for people living with HIV. Report of a joint WHO HIV/AIDS and TB department meeting. Geneva, Switzerland: HIV/AIDS Department, World Health Organization; April, 2008. http://www.who.int/hiv/pub/tb/3is-mreport/en/index.html
2. World Health Organization. Interim Policy on collaborative TB/ HIV activities. Geneva: WHO Press; 2004. Report No. WHO/ HTM/TB/2004. 330. http://www.who.int/tb/publications/tbhiv- interim-policy/en/index.html. [Accessed 4 May 2010].
3. Comstock GW, Ferebee SH, Hammes LM. A controlled trial of community-wide isoniazid prophylaxis in Alaska. Am Rev Respir Dis 1967; 95:935-943.
4. Anonymous. Tuberculosis preventive therapy in HIV-infected individuals. A joint statement of the WHO Tuberculosis Programme and the Global Programme on AIDS and the International Union against Tuberculosis and Lung Disease (IUATLD). Weekly Epidemiologic Record 1993; 68:361-364.
5. World Health Organization. Policy statement on preventive therapy against tuberculosis in people living with HIV. Geneva: World Health Organization; February 1998. http://www. who.int/tb/publications/1998/en/index2.html. [Accessed 4 May 2010].
6. Getahun H, Kittikraisak W, Heilig C, Corbett E, Ayles H, Cain K, et al. Development of a standardized screening rule for tuberculosis in people living with HIV in resource constrained settings: individual participant data meta-analysis of observational studies. PLoS Medicine (in press).
7. World Health Organization. Global tuberculosis control: a short update to the 2009 report. Geneva: WHO press 2009. Report No. WHO.TB.98.225. http://whqlibdoc.who.int/ publications/2009/9789241598866-eng.pdf. [Accessed 4 May 2010].
8. Getahun H, Gunneberg C, Granich R, Nunn P. Implementation of isoniazid preventive therapy for people living with HIV worldwide: challenges and solutions. AIDS 2010; 24 (Suppl 5): S57-S65.
9. Hanifa Y, Grant AD, Lewis J, Corbett EL, Fielding K, Churchyard G. Prevalence of latent tuberculosis infection among gold miners in South Africa. Int J Tuberc Lung Dis 2009; 13:39-46.
10. Lewis J, Charalambous S, Day J, Fielding K, Grant AD, Hayes R, et al. HIV infection does not affect active case finding of tuberculosis in South African gold miners. Am J Respir Crit Care Med 2009; 180:1271-1278.
11. Churchyard G, Coetzee L, Fielding K, Chihoto V, Herselman P, Grant AD, et al. Contribution of TB screening as part of community-wide IPT to TB case finding among South African gold miners [abstract PS-82413-20]. In: Program and Abstracts of the 39th Union World Conference on Lung Health; 16-20 October 2008; Paris.
12. Churchyard GJ, Fielding KL, Lewis JJ, Chihota VN, Hanifa Y, Grant AD. Symptom and chest radiographic screening for infectious tuberculosis prior to starting isoniazid preventive therapy: yield and proportion missed at screening. AIDS 2010; 24 (Suppl 5):S19-S27.
13. Grant AD, Mngadi KT, van Halsema CL, Luttig MM, Fielding KL, Churchyard GJ. Adverse events with isoniazid preventive therapy: experience from a large trial. AIDS 2010; 24 (Suppl 5): S29-S36.
14. Grant AD, Coetzee L, Fielding KL, Lewis JJ, Ntshele S, Luttig MM, et al. 'Team up against TB': promoting involvement in Thibela TB, a trial of community-wide tuberculosis preventive therapy. AIDS 2010; 24 (Suppl 5):S37-S44.
15. Lester R, Hamilton R, Charalambous S, Dwadwa T, Chandler C, Churchyard GJ, Grant AD. Barriers to implementation of iso-niazid preventive therapy in HIV clinics: a qualitative study. AIDS 2010; 24 (Suppl 5):S45-S48.
16. Charalambous S, Grant AD, Innes C, Hoffman C, Dowdeswell R, Pienaar J, et al. Association of isoniazid preventive therapy with lower early mortality in individuals on antiretroviral therapy in a workplace programme in South Africa. AIDS 2010; 24 (Suppl 5):S5-S13.
17. Grant AD, Fielding KL, Charalambous S, Chaisson R, Churchyard G. Viewpoint: why have IPT trials among people with HIV infection not demonstrated an effect on mortality? AIDS 2010; 24 (Suppl 5):S15-S18.
18. Moulton L, Golub JE, Durovni B, Cavalcante SC, Pacheco AG, Chaisson RE, et al. Statistical design of THRio: a phased implementation clinic-randomized study of a tuberculosis preventive therapy intervention. Clin Trials 2007; 4:190-199.
19. Durovni B, Saraceni VL, Calvacante SC, Moulton LH, King B, Chaisson RE, Golub JE. The implementationof IPTin HIV clinics: the experience from Brazil. AIDS 2010; 24 (Suppl 5):S49-S56.
20. Golub J, Saraceni V, Cavalcante SC, Pacheco AG, Moulton LH, Durovni B, et al. The impact of antiretroviral the rapyand is oniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil. AIDS 2007; 21:1441-1448.
21. Ayles H, Sismandis C, Beyers N, Hayes RJ, Godfrey-Faussett P. ZAMSTAR, The Zambian South Africa TB and HIV Reduction study: design of a 2 x 2 factorial community randomized trial. Trials 2008; 9:63.